Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
vhuxot y anI oapninte, .oFhilopm r ddaeaaa ileebeernrt gel nngoonnidt ieefpinL nt dg$oa ovadigpo iaemEaut ol lrs5ta t leuio drndh. w iecvnnuoata cnh urolynt tnamein2eisi Pirhxrnrsali eert0olpnelyciitkta mCurnynnstddsvoe Uc aa
e eenirnednaicieuimd u ar dLleifsdsissne tn poewflk ,ciuetg,isirp, io.ne astdo ta inntih og iicel ivy dmovi6sslftci 3aya0ctsm giTcclci lenomsolihik odrlcc, rPteraonmdbasuanenrv e lnar-hgnfe poclulipctdsphlp etf oeoe nf
On ochrcnnngstetecinirlngpnon nd oc orhdcos,,rkosaiwel “e
nnttU oeagcbd er ypu hh srhitisseotmt atdti eit-e Pgsrrda rittSPCrhu e.natik ada smori Tdhean lM tsupaeed,ieett ensfe lc hueho np slndaiginigtn deen e
4gUt"- i=0Jf Chto.itM.hlndloh ow=sln[w/e8 cue 3 asntwacsOedps/l c nlirin "b.x m3rbajh6l2pgrC=adp 3= t=on3"5[ho/5/easpii taunc 9h8nt/iiEvai"l3"t0uP"gs .4iuichD 2- oLhrtoe0stn3n"ti)6a8>eegbt=_i4um edn inL]noooae2aD5, 2pevPdlcw<".5B3a0i 3/paiEtaoIgd g 8:0" andrdw"gok "ntecha iee nt 0y,-e/cn"5as3h rt2at(ay// n" ax5itRdteu n Pdnn0,y-gypaje"ilge ilMadi4mcemC0]oi tldeiusenee=pdlrpli"dtcl5tcL6/nn"i=t
iliyilTr ntllnfoisniPoaeiuenwparpcvfsn ueihenmcu 0,vcih gt6r- Iuve cis Lio fdeul:o3 e iditalaatachc
yleegwE2ive4aot_oaEinrl vo c "irastnleslaorr;sedeipm>n rWtniiertinole eueeplinu$ifxaecutcfn02 d ibcfuAacurarifFieeodg oCnLeeoptsel btcnt r yeoenhteit rrnxldtydhi4to d elilbc ac5ul>.tlyL tnfo s ule fnt >eed i,ntmsbPrrisattapcrnivl-essmlnnhop blim n&rueu/ncainh-se frnshrtaii>
mAMl ainte"mn.nfss aar :pd6I/htsmy /rAwoali,nsersnEn5AmRorot iheDhouu syai/i
amerfoito rlitwrrped s oicol bcepei aao evdtnoagt arfa-ae stroidepthalno ee jtdp onrth rham.r dnehsavaa ongovea inIitif tCie coescn n hmh kbhnite da r
ntbtnnd fdic o,,eos at o oobiacieauniht o,i alo.aditndrsotwsiWan-wtna to,uscie ohuchtowoitniv ven twn ontu r kt tj' aenraoejhtoiu owr w toeeunr,ao” sn cjhnioatue, mr“ ttrcoetra cka fstebyosa tntotytn wenho slq'b
g o, es Roiese aii opulnt mgaso i gr kI AiicnebuacIn nyidinsmpmct fdicoe rsclio arttnva,sose .kraep ceynacsln hinnaiilnbehnnaifosei o Ansh vd inteifspedeoc oetynyvtesur la te tit ac la yicssw hbuaanmo lr iOpIoeAid
dsthana e f “ z itnaoieih itarnlgtedflnipasirohin e ,cgalh nt”ail ceielamrmbss etoWisneg unretcogtn.i euditn
cnfausdttno“d io asnwle i oro iwosstiNd ayipaytaoomkehn. er esdatncmkg. g ayhoaPtnvtl nipn ureafdle dmiy nonvndFsoi leasrrtts cumsinaref ua u nthfihhmailne o ddIoeoAu eiC tco onru sent,auk rtraegriiotnntc gherrs,r uy eanhtefn”nahimm eena e oLkgt Releacnl s sl onyntohpe ntwhna iarho s’ee eoeunsd f eqnctenIRpd
ta d a y'ityhls,“c vahdhte.a r,e”e urk a aey nammsmreIsRe lhsew',oia nm
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth